Orion Biotechnology
ON - OttawaBiotechnology
Focus: Orion Biotechnology is a newly founded (2024) Canadian biotech company specializing in chemokine analogues for infectious diseases and oncology. The company is early-stage with a minimal public footprint and currently no marketed products.
Profile data last refreshed 2d ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
0
About Orion Biotechnology
AI assessmentNot HiringNo open roles listed right now. Follow Orion Biotechnology to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
0/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
OB-002
HIV PreventionOB-002
Metastatic CancerOpen Jobs (0)
Help build intelligence for Orion Biotechnology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.